Head of Program Lead.

 

AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs. At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge science with advanced technology. Powered by physics-based modeling, statistical mechanics, and generative AI, QEMI allows our teams to design novel drug candidates from first principles.

 

What makes AQEMIA different is our commitment to true innovation: our research is dedicated to the invention of new molecular entities, not the refinement of existing ones. We focus on inventing never-before-seen molecules, without relying on experimental data, and advancing them into a growing pipeline of proprietary programs and strategic partnerships with leading pharmaceutical companies.

 

Our most advanced preclinical programs are currently in vivo optimization, targeting diseases still waiting for effective treatments, offering our teams the opportunity to work on science that can make a real difference in people’s lives.

 

For more information, visit AQEMIA.com, our WTTJ Page, and our LinkedIn. 

 

 

AQEMIA brings together a diverse, multidisciplinary team of 80+ professionals based in Paris and London. Our scientists and engineers, including chemists, physicists, machine learning experts, and software engineers, work side by side to push the boundaries of early-stage drug discovery.

 

This close collaboration across disciplines is central to our approach, enabling us to tackle complex scientific challenges from first principles and translate cutting-edge ideas into novel therapeutic candidates. At AQEMIA, team members are encouraged to contribute their expertise, learn from one another, and play an active role in shaping the future of drug invention.

Scientific background PhD (Chemistry, Biology) preferred, MD, PharmD or Engineer 

Experience in consulting in lifesciences (past or current experience) with a focus on asset positioning or R&D portfolio management

Strategic thinker with strong analytical depth

Experience in startup biotech or CRO is a plus

Excellent leadership and people management capabilities, including experience managing, hiring and developing talent

Exceptional communication and stakeholder management skills.

Comfortable at navigating ambiguity.

Curious, quick learner and problem solver

Passionate about contributing to a mission-driven biotech company changing how drugs are discovered.

Motivated by solving hard problems and making strategic decisions in uncertain environments.

Eager to coach, mentor, and collaborate across disciplines.

Highly organized and adaptable in a fast-paced, evolving setting.

1 - First discussion with our Talent Acquisition

2 - Hiring Manager’s interview : you’ll meet directly with your future manager

3 - Technical assessment of your skills through a Business Case

4 - Cultural fit interview with our co-founder and COO Emmanuelle

5 - Final interview with our co-founder and CEO Maximilien

 

 

Expanding Drug Discovery Pipeline : Focused on critical therapeutic areas like Oncology, CNS, Immuno-inflammation... with in vivo proof of concept/patent stage programs. Collaborations with top Pharma, including a $140M Sanofi deal.

World-Class Interdisciplinary Team : work alongside exceptional talent at the intersection of technology and life sciences. Our teams combine deep expertise in AI, physics-based modeling, biology, and medicinal chemistry to push the boundaries of innovation.

DeepTech Recognition: AQEMIA is proud to be part of the French Tech 40 and France 2030, highlighting our role as a key player in Europe’s DeepTech ecosystem.

Prime Location with Flexibility : Our offices are located in the heart of Paris and London (King’s Cross), with flexible work arrangements including up to two remote days per week.

Strong Financial Backing : $100M raised from leading European and International investors